🟢 10x Genomics is trading 4.1% up today as risk sentiment improves after sector-led pullback

10x Genomics is trading at $49.20 (4.1%) up in pre-market as the stock rebounds from a recent biotech-led pullback.

• The move appears driven by firmer index futures and improving risk sentiment rather than company-specific news or earnings.
• Recent coverage suggests prior downside was caused by broader sector weakness rather than issues specific to the company.